期刊文献+

双过氧钒化合物NH4[OV(O2)2(C8H7N3)]·4H2O抗肿瘤活性研究 被引量:1

Antitumor Activity of a New Complex of Diperoxovanadate NH_4[OV(O_2)_2(C_8H_7N_3)]·4H_2O
原文传递
导出
摘要 在细胞和动物实验水平上,研究了双过氧钒化合物NH4[OV(O2)2(C8H7N3)]×4H2O(简写bpV(Imi-Py))对癌细胞的增殖作用,碱性磷酸酶的活性抑制和体内抗肿瘤作用.研究结果显示bpV(Imi-Py)对胃癌细胞株MGC-803、肺癌细胞株95D和L342的IC50值分别为8.27、26.37和9.54μmol/L,而对人正常肾胚胎细胞HEK293的IC50值达6 642μmol/L,表明该化合物对肿瘤细胞具有特异杀伤作用.研究还表明bpV(Imi-Py)对MGC-803细胞提取液的碱性磷酸酶(ALP)也有明显抑制作用,呈现量效关系.动物体内抗肿瘤实验发现bpV(Imi-Py)能抑制肝癌细胞生长,肿瘤体积实验组较对照组下降35.6%,表明bpV(Imi-Py)有较好的抗肿瘤活性.另外,小鼠急性毒性实验的LD50为147.2mg.kg-1,说明bpV(Imi-Py)是一种中等毒性的抗肿瘤化合物.图4,表1,参15. A diperoxovanadate complex NH4[OV (O2) 2{2-( 2'-pyridyl )-imidazole}]×4H20, bpV ( Imi-Py ) for short, was investigated at the level of cell and animal based on its proliferation on cancer cells, inhibition on alkaline phosphatase and anti-tumor in animal experiments. The results showed that the IC50 values of bpV (Imi-Py) for gastric cancer cell line MGC-803, lung cancer cell line 95D and L342 were 8.27, 26.37, and 9.54 μmol/L, respectively. However, its IC50 value for normal human embryonic kidney cell cultures HEK293 is 6642 μ mol/L, indicating that cancer cells can be selectively inhibited by bpV (Imi-Py). The inhibition of bpV (Imi-Py) on alkaline phosphatase is also obvious, and showed the dose-response relationship. At the same time, animal tumor trail showed that bpV (Imi-Py) inhibited hepatocarcinoma cells. The volume of tumor was reduced by about 35.6% relative to control. It suggests that bpV (Imi-py) has good anti-tumor activity. In addition, the LD50 of bpV (Imi-Py) is 147.2 mg· kg^-1 intravenously in mice, indicating its moderate toxicity. In conclusion, bpV (Imi-Py) is one kind of anti-tumor complex with :moderate toxicity.
出处 《湖南科技大学学报(自然科学版)》 CAS 北大核心 2008年第1期101-105,共5页 Journal of Hunan University of Science And Technology:Natural Science Edition
基金 厦门市重大疾病攻关研究基金(3502Z20051027) 卫生部福建省卫生教育联合攻关计划(Wkj2005-2-019) 湖南省自然科学基金(06JJ30004)
关键词 双过氧钒 抗肿瘤活性 毒性 diperoxovanadate complex toxicity antitumor activity
  • 相关文献

参考文献12

  • 1[1]Utler A,Clague M J,Meister G E.Vanadium Peroxide Complexes[J].Chem Rev,1994.94(3):625-638.
  • 2[2]Thompaon K H,Orvig C.Boon and Bane of Metal Ions in Medicine[J].Science,2003,300(5621):936-939.
  • 3[3]Crans D C,Smee J J,GAIDAMAUSKAS E,et al.The Chemistry and Biochemistry of Vanadium and the Biological Activities Exerted by Vanadium Compounds[J].Chem Rev,2004,104(2):849-902.
  • 4[4]Hwang J H,Larson R K,Abu-Omar M M.Kinetics and Mechanistic Studies of Anticarcinogenic Bisperoxovanadium(V)Compounds:Ligand Substitution Reactions at Physiological pH and Relevance to DNA Interactions[J].Inorg Chem,2004,42(24):7967-7977.
  • 5[5]Bell J H,Pratt R F.Mechanism of Inhibitim of the β-lactanmae of Enterobacter Cloacae P99 by 1:1 Complexos of Vanadate with Hydroxamic Acids[J].Biochemistry,2002,41(3):4329-4338.
  • 6[6]Morinville A,Maysinger D,Shaver A.From Vanadis to Atropos:Vanadium Compounds as Pharmacological Tools in Cell Death Signalling[J].Trends Pharmacol Sci,1998,19(11):452-60.
  • 7[7]Evangelou A M.Vanadium in Cancer Treatmeat[J].Critical Reviews in Oncology/Hematology,2002,42(3):249-265.
  • 8[8]Faure R,Vaysinger M,Dufour M,et al.Arrest at the G2/M Transition of the Cell Cycle by Protein-tyrosine Phosphatase Inhibition:Studies on a Neuronal and a Glial Cell Line[J].J Cell Biochem,1995,58:389-401.
  • 9[9]Doilon C J,Faure R L,Posner B I,et al.Peroxovanadium Compounds as Inhibitors of Angiogenesis[J].Angiogenesis,1999,3(4):361-369.
  • 10[10]Posner B I,Faure R,Burgess J W,et al.Peroxovanadium Compounds:a New Class of Potent Phosphotymsine Phosphate Inhibitors which are Insulin Mimetics[J].J Biol Chem,1994,269(6):4596-4604.

同被引文献27

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部